Início › Câncer Colorretal › Washington

Ensaios clínicos de Câncer Colorretal em Washington

46 estudos para Câncer Colorretal estão buscando participantes em locais em Washington.

Cidades em Washington

Texto oficial do estudo (Inglês)

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Valley Medical Center, Renton

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05673148

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

University Of Washington-Fred Hutchinson Cancer Center - Seattle /ID# 281451, Seattle

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07525206

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of Washington, Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 1/2

Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Providence Regional Cancer System-Aberdeen, Aberdeen
PeaceHealth Saint Joseph Medical Center, Bellingham
Providence Regional Cancer System-Centralia, Centralia
e mais 19

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

Family Communications After Genetic Testing

Providence Regional Cancer System-Aberdeen, Aberdeen
PeaceHealth Saint Joseph Medical Center, Bellingham
Providence Regional Cancer System-Centralia, Centralia
e mais 17

RecrutandoVoluntários saudáveis bem-vindos

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07143487

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06625775

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Fred Hutchinson Cancer Research Center, Seattle

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06324357

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

Virginia Mason Medical Center, Seattle

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07659795

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

University Of Washington-Fred Hutchinson Cancer Center - Seattle /ID# 271298, Seattle

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT06820463

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Northwest Medical Specialties, PLLC, Bonney Lake
Swedish Cancer Institute - Edmonds Campus, Edmonds
Swedish Medical Center - Edmonds, Edmonds
e mais 9

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07222800

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Fred Hutchinson Cancer Center, Seattle

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT04981119

A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

Swedish Cancer Institute, Seattle

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06663319

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Providence Regional Cancer System, Lacey
Fred Hutchinson Cancer Research Center, Seattle

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06750094

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Swedish Cancer Institute Edmonds, Edmonds
Swedish Cancer Institute Issaquah, Issaquah
Swedish Cancer Institute, Seattle
e mais 1

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06662786

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Northwest Medical Specialties, Tacoma

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06047379

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Local Institution - 0491, Edmonds
Local Institution - 0253, Seattle
Local Institution - 0629, Spokane
e mais 1

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07221357

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06445062

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Fred Hutchinson Cancer Research Center, Seattle

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT05786924

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Vista Oncology Inc Ps, Olympia

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07284849

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Clinical Study Site, Spokane
Clinical Study Site, Tacoma

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT07228832

The Vanguard Study: Testing a New Way to Screen for Cancer

Madigan Army Medical Center, Tacoma

RecrutandoVoluntários saudáveis bem-vindos

Idades de 45 a 75 · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06995898

Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education

Benaroya Research Institute at Virginia Mason, Seattle
Fred Hutch/University of Washington Cancer Consortium, Seattle

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT06995924

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

Swedish Cancer Institute, Seattle

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT06992258

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT06586515

Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients

University of Washington, Seattle

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT05410977

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 13 de ago. de 2026 · NCT07066657

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Wenatchee Valley Hospital and Clinics, Wenatchee

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT06330064

A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)

GSK Investigational Site, Wenatchee

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 3 de ago. de 2026 · NCT06885034

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

University Of Washington, Seattle

RecrutandoFase 1

Idades de 18 a 100 · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT06562192

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Georgetown University Medical Center, Georgetown
Cancer Care Northwest, Spokane

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT03526835

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

Providence Regional Cancer Partnership, Everett
Providence Regional Medical Center Everett, Everett
Northwest Cancer Specialists, P.C., Vancouver

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de jul. de 2026 · NCT05253651

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

Medstar Speciality Hospital, Northwest

RecrutandoFase 4

Idades 18 e acima · Todos os sexos · Atualizado em 7 de jul. de 2026 · NCT06562543

A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial

Fred Hutch/University of Washington Cancer Consortium, Seattle

RecrutandoVoluntários saudáveis bem-vindos

Idades de 45 a 75 · Todos os sexos · Atualizado em 22 de jun. de 2026 · NCT06822530

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Medical Oncology Associates, Spokane

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 18 de jun. de 2026 · NCT07503808

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 12 de jun. de 2026 · NCT06051695

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 2 de jun. de 2026 · NCT06917079

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Virginia Mason Medical Center, Seattle

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 15 de mai. de 2026 · NCT05379985

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Virginia Mason Medical Center, Seattle

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de abr. de 2026 · NCT07020221

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

Providence Regional Cancer System-Aberdeen, Aberdeen
PeaceHealth Saint Joseph Medical Center, Bellingham
Providence Regional Cancer System-Centralia, Centralia
e mais 17

RecrutandoFase 3Voluntários saudáveis bem-vindos

Idades 18 e acima · Todos os sexos · Atualizado em 31 de mar. de 2026 · NCT07018869

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 27 de mar. de 2026 · NCT06395519

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.